Valsartan Tablet
Product Images NDC 51655-695

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 51655-695). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 695 52 Master Bottle Label Approval Rev A 03 21)

This is a description of Valsartan tablets, a prescription-only medication used for treating high blood pressure and heart failure. One package contains 30 tablets of 160mg each. The recommended dose can be found in the package insert. The tablets should be stored between 20°-25°C and protected from moisture. Children should not have access to the medication. The pills have been repackaged by Northwind Pharmaceuticals and are labeled with a GTIN number. There is an expiration date on the package, but it has been removed from this text.*

FDA Label Image

Figure01 (Fig01)

This appears to be a table showing the comparison between two drugs, Valsartan and Captopril, for patients in various subgroups based on age (<65 or >65), sex (male or female), race (Caucasian or non-Caucasian), US residency status (US or non-US), and whether or not they were taking beta-blockers. The table also includes the number of patients in each subgroup, and the percentage of patients favoring each drug within that subgroup.*

FDA Label Image

Structuralformula (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.